Sunesis Pharmaceuticals Corporate Update Call Scheduled to start Mon, Jun 6, 2011, 9:00 am Eastern
Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. Its lead product candidate is Voreloxin, an anticancer quinolone derivative (AQD) for the treatment of cancer. The company is conducting various clinical trials of Voreloxin, including a Phase 2 clinical trial, known as the REVEAL-1 trial, in previously untreated elderly patients with acute myeloid leukemia (AML); a Phase 1b/2 clinical trial combining Voreloxin with cytarabine for the treatment of patients with relapsed/refractory AML; and a Phase 2 single agent clinical trial in platinum-resistant ovarian cancer patients. It has a license agreement with Dainippon Sumitomo Pharma Co., Ltd. for the development and marketing of Voreloxin; and a collaboration agreement with Biogen Idec, Inc. to discover, develop, and commercialize small molecule inhibitors of Raf kinase and up to five additional targets that play a role in oncology and immunology indications. The company, formerly known as Mosaic Pharmaceuticals, Inc., was founded in 1998 and is headquartered in South San Francisco, California
AAU is going to run hard. Someone is really playing with this one. Today was like the 3rd day they run it up on buying and then pull it back. Someone is trying hard to keep this from breaking that 3.85 level. Shares in this level are drying up big time. I mean into the close they take it down to 3.56 on some small volume and it then it up ticks right back to 3.64 on almost nothing. I think this one breaks 3.85 soon and will probably see 4.40 or so. Just wait until that 50 DMA and 200 DMA cross that is when we see a big move. My money says it takes out 5.45 soon and makes new highs to the 6.25-6.50 range.
Market Data 
Markets 
AI
